Hugel Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
29,170
40,350
65,066
124,189
182,085
Cost of Goods Sold (COGS) incl. D&A
8,186
12,362
27,616
31,551
42,201
Gross Income
20,984
27,988
37,450
92,638
139,885
SG&A Expense
9,425
12,588
19,692
29,378
37,961
EBIT
11,559
15,400
17,757
63,260
101,924
Unusual Expense
866
214
31,025
378
-
Non Operating Income/Expense
64
357
50,541
1,693
36
Interest Expense
1,068
1,086
34
-
1,493
Pretax Income
10,034
15,266
37,666
65,789
103,549
Income Tax
2,081
2,465
3,454
13,434
22,198
Equity in Affiliates
647
350
1,645
1,454
-
Consolidated Net Income
7,307
13,150
35,857
50,901
81,351
Net Income
7,307
13,150
33,929
43,273
72,827
Net Income After Extraordinaries
7,307
13,150
33,929
43,273
72,827
Net Income Available to Common
7,307
13,150
33,929
43,273
72,827
EPS (Basic)
2,224.85
4,004.32
13,361.00
13,265.00
19,475.00
Basic Shares Outstanding
3
3
3
3
4
EPS (Diluted)
2,224.85
4,270.73
12,248.76
12,812.09
18,697.22
Diluted Shares Outstanding
3
3
3
3
4
EBITDA
12,134
16,008
19,307
68,070
108,686
Non-Operating Interest Income
344
809
427
1,213
5,040
Minority Interest Expense
-
-
1,928
7,628
8,523
Equity in Affiliates (Pretax)
-
-
-
-
1,958

About Hugel

View Profile
Address
61-20 Sinbuk-ro
Chuncheon-si GA 24206
Korea, Republic Of
Employees -
Website http://www.hugel.co.kr
Updated 09/14/2018
Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. Its products include botulinum toxin, hyaluronic acid fillers, facial masks, concealers, and moisturizers. The company was founded on November 22, 2001 and is headquartered in Chuncheon-si, South Korea.